Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Fang

Showing results (421-430 of 438) with videos related to

Pageof 44
Sort By:
Journal of the Chinese Medical Association : JCMA|October 13, 2021
Clinicopathological characteristics and treatment outcomes of luminal B1 breast cancer in TaiwanBo-Fang Chen, Yi-Fang Tsai, Chi-Cheng Huang, et al.
European Journal of Medicinal Chemistry|February 17, 2024
Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5]Bo Fang, Yinshuang Lai, Hao Yan, et al.
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
European Journal of Medicinal Chemistry|August 9, 2023
Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancerBo Fang, Yinshuang Lai, Hao Yan, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
Journal of Ethnopharmacology|February 29, 2024
Effective substances and molecular mechanisms guided by network pharmacology: An example study of Scrophulariae Radix treatment of hyperthyroidism and thyroid hormone-induced liver and kidney injuriesMeng-Yuan Sheng, De-Wei Peng, Hui-Ming Peng, et al.
Planta Medica|August 6, 2021
Competitive CatSper Activators of Progesterone from Rhynchosia volubilisJin Xiang, Hang Kang, Hong-Gang Li, et al.
Nature Communications|March 27, 2026
Smart-flame-retarding layered composite Li negative electrode for safe Li metal batteryHaoying Qi, Lequan Deng, Yaoyao Liu, et al.
Frontiers in Immunology|December 6, 2021
GII.P16-GII.2 Recombinant Norovirus VLPs Polarize Macrophages Into the M1 Phenotype for Th1 Immune ResponsesJi Cheng Han, Qiu Xuan Li, Jin Bo Fang, et al.
BMC Cardiovascular Disorders|September 18, 2024
Association between admission blood pressure and spontaneous reperfusion and long-term prognosis in STEMI patients: an observational and multicenter studyZheng Hu, Da Luo, Wen-Jie Zhou, et al.
Pageof 44

Showing results (421-430 of 438) with videos related to

Sort By:
Pageof 44
Journal of the Chinese Medical Association : JCMA|October 13, 2021
Clinicopathological characteristics and treatment outcomes of luminal B1 breast cancer in TaiwanBo-Fang Chen, Yi-Fang Tsai, Chi-Cheng Huang, et al.
European Journal of Medicinal Chemistry|February 17, 2024
Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5]Bo Fang, Yinshuang Lai, Hao Yan, et al.
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
European Journal of Medicinal Chemistry|August 9, 2023
Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancerBo Fang, Yinshuang Lai, Hao Yan, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
Journal of Ethnopharmacology|February 29, 2024
Effective substances and molecular mechanisms guided by network pharmacology: An example study of Scrophulariae Radix treatment of hyperthyroidism and thyroid hormone-induced liver and kidney injuriesMeng-Yuan Sheng, De-Wei Peng, Hui-Ming Peng, et al.
Planta Medica|August 6, 2021
Competitive CatSper Activators of Progesterone from Rhynchosia volubilisJin Xiang, Hang Kang, Hong-Gang Li, et al.
Nature Communications|March 27, 2026
Smart-flame-retarding layered composite Li negative electrode for safe Li metal batteryHaoying Qi, Lequan Deng, Yaoyao Liu, et al.
Frontiers in Immunology|December 6, 2021
GII.P16-GII.2 Recombinant Norovirus VLPs Polarize Macrophages Into the M1 Phenotype for Th1 Immune ResponsesJi Cheng Han, Qiu Xuan Li, Jin Bo Fang, et al.
BMC Cardiovascular Disorders|September 18, 2024
Association between admission blood pressure and spontaneous reperfusion and long-term prognosis in STEMI patients: an observational and multicenter studyZheng Hu, Da Luo, Wen-Jie Zhou, et al.
Pageof 44